Cassava Sciences Announces Fireside Chat and Presentation Tuesday, April 5th
31 March 2022 - 12:00AM
Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage
biotechnology company focused on Alzheimer’s disease, today
announced that Remi Barbier, its President & CEO, will discuss
clinical and corporate updates for Q1 2022 in a fireside chat and
presentation on Tuesday, April 5, 2022, at 9am Eastern time.
This event, open to the public, will be
conducted exclusively via webcast.
Stakeholders are encouraged to submit questions
or comments for management’s consideration. Please email in advance
of the event your questions and full name
to: SAVAquestionsQ1@CassavaSciences.com
Management may not be able to address all
comments or questions due to SEC Regulation Fair Disclosure (FD),
limits around legal disclosures, time constraints or other
limitations.
Detailed instructions on how to attend the
webcast will be made available prior to the event. A webcast of
Cassava Sciences’ fireside chat will be available for replay
following the event on www.CassavaSciences.com in the
‘Investors’ section.
About Cassava Sciences,
Inc.Cassava Sciences’ mission is to discover and develop
innovations for chronic, neurodegenerative conditions. Over the
past 10 years, Cassava Sciences has combined state-of-the-art
technology with new insights in neurobiology to develop novel
solutions for Alzheimer’s disease. We are currently testing
simufilam, our lead drug candidate for the proposed treatment of
Alzheimer’s disease, in Phase 3 clinical studies under Special
Protocol Assessments from the FDA. Simufilam is also being tested
in an open-label study and a randomized, double-blind,
placebo-controlled Cognition Maintenance Study in patients with
Alzheimer’s disease.
For more information, please visit:
https://www.CassavaSciences.com
For More Information Contact:
Eric Schoen, Chief Financial
OfficerESchoen@CassavaSciences.com(512) 501-2450
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Oct 2023 to Oct 2024